Evidence map›Paper›PMID 31761566›Full record

ArticleCell metabolism2020

Neutralization of Oxidized Phospholipids Ameliorates Non-alcoholic Steatohepatitis.

Xiaoli Sun, Jason S Seidman, Peng Zhao, Ty D Troutman, Nathanael J Spann, Xuchu Que, Fangli Zhou, Zhongji Liao, Martina Pasillas, Xiaohong Yang and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 108 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
108citing papers in PubMed, 1 pooled it
14.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

108 citing papers in PubMed, 1 synthesis or guideline pooled it, 195 citations in OpenAlex.

  1. Oxidized Phospholipids and Calcific Aortic Valvular Disease.Journal of the American College of Cardiology · 2024
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Caspase-6 Controls Lipid and Energy Metabolism in Diet-Induced Obesity.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  7. Article
  8. Single Cell Analysis Reveals the Presence of Novel Intermediate Cells in Both Mice and Patients With Severe MASLD.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. IgM Antibodies Targeting Malondialdehyde Promote Complement-Mediated Liver Injury in Alcohol-Related Liver Disease.Liver international : official journal of the International Association for the Study of the Liver · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

48 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 2 countries.

Xiaoli SunDepartment of Medicine, University of California, San Diego, La Jolla, CA 92093, USA. Electronic address: x10sun@ucsd.edu.
Jason S SeidmanDepartment of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
Peng ZhaoDepartment of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
Ty D TroutmanDepartment of Medicine, University of California, San Diego, La Jolla, CA 92093, USA; Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
Nathanael J SpannDepartment of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
Xuchu QueDepartment of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
Fangli ZhouDepartment of Medicine, University of California, San Diego, La Jolla, CA 92093, USA; Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China.
Zhongji LiaoDepartment of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
Martina PasillasDepartment of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
Xiaohong YangDepartment of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
Jason A MagidaGene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
Tatiana KisselevaDepartment of Surgery, University of California, San Diego, La Jolla, CA 92093, USA.
David A BrennerDepartment of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
Michael DownesGene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
Ronald M EvansGene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
Alan R SaltielDepartment of Medicine, University of California, San Diego, La Jolla, CA 92093, USA; Department of Pharmacology, University of California, San Diego, La Jolla, CA 92093, USA.
Sotirios TsimikasDepartment of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
Christopher K GlassDepartment of Medicine, University of California, San Diego, La Jolla, CA 92093, USA; Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
Joseph L WitztumDepartment of Medicine, University of California, San Diego, La Jolla, CA 92093, USA. Electronic address: jwitztum@ucsd.edu.
University of California, San Diego · USSalk Institute for Biological Studies · USSichuan University · CN

Funding

VIRAL MALIGNANCYP30CA023100 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jesse Nodora · 1985 to 2026
$124.9M
Viral Vector Core (VVC)P30CA014195 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI Reuben Shaw · 1985 to 2026
$82.8M
Yeast Genetics and Stress Response Genes-BiomedicalP42ES010337 · NIEHS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TUKEY, ROBERT H · 2000 to 2022
$69.8M
The Southernearch Center for ALPD and CirrhosisP50AA011999 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ANNA S. GUKOVSKAYA · 1999 to 2026
$45.8M
Transgenic & Knock-out MouseP30DK063491 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Andrea L Hevener · 2003 to 2026
$40.4M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007198 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHI, NEIL C, INSEL, PAUL A · 1985 to 2024
$29.3M
Transcriptional GenomicsP01HL088093 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WITZTUM, JOSEPH L. · 2008 to 2018
$26.4M
Project 4: APOB-specific CD4 and CD8 T cells exacerbate atherosclerosisP01HL136275 · NHLBI · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI Catherine C Hedrick · 2017 to 2026
$25.5M
HORMONAL REGULATION OF MAMMALIAN GENE EXPRESSIONR37DK057978 · NIDDK · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI EVANS, RONALD M · 2000 to 2019
$16.0M
Contemporary Approaches to Cancer Cell Signaling and CommunicationT32CA009523 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DONOGHUE, DANIEL J, YANG, JING · 1985 to 2025
$12.1M
AIBP therapyR35HL135737 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MILLER, YURY · 2017 to 2023
$6.5M
Inactivation of Hepatic Stellate Cells During Reversal of Liver FibrosisR01DK099205 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BRENNER, DAVID A., KISSELEVA, TATIANA · 2014 to 2025
$4.8M
NCI NIH HHS P30 CA014195NCI NIH HHS P30 CA023100NCI NIH HHS T32 CA009523NHLBI NIH HHS K99 HL143277NHLBI NIH HHS P01 HL088093NHLBI NIH HHS P01 HL136275NHLBI NIH HHS R00 HL143277NHLBI NIH HHS R01 HL105278NHLBI NIH HHS R35 HL135737NIAAA NIH HHS P50 AA011999NIAAA NIH HHS U01 AA022614NIDDK NIH HHS P30 DK063491NIDDK NIH HHS R01 DK099205NIDDK NIH HHS R01 DK101737NIDDK NIH HHS R01 DK111866NIDDK NIH HHS R37 DK057978NIDDK NIH HHS T32 DK007044NIEHS NIH HHS P42 ES010337NIGMS NIH HHS R01 GM065490NIGMS NIH HHS T32 GM007198NIH HHS S10 OD023527
6 · The paper itself

Abstract

Oxidized phospholipids (OxPLs), which arise due to oxidative stress, are proinflammatory and proatherogenic, but their roles in non-alcoholic steatohepatitis (NASH) are unknown. Here, we show that OxPLs accumulate in human and mouse NASH. Using a transgenic mouse that expresses a functional single-chain variable fragment of E06, a natural antibody that neutralizes OxPLs, we demonstrate the causal role of OxPLs in NASH. Targeting OxPLs in hyperlipidemic Ldlr

Indexed as

Oxidative StressAnimalsApoptosisCarcinoma, HepatocellularDiet, High-FatFatty LiverGene OntologyHepatocytesHumansInflammationLiver CirrhosisLiver NeoplasmsMaleMiceMice, Inbred C57BLMice, TransgenicPhospholipidsReactive Oxygen SpeciesSingle-Chain AntibodiesatherosclerosisfibrosisinflammationmitochondriaMnSODnatural antibodynonalcoholic steatohepatitisoxidative stressoxidized phospholipidssteatosis

Identifiers

PMID31761566
PMCPMC7028360
OpenAlexW2991127841

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.